Pediatric
Ravulizumab-cwvz
Ravulizumab-cwvz Ravulizumab-cwvz: Ravulizumab-cwvz (Ultomiris®) is a drug approved by the U.S. Food and Drug Administration (FDA) in 2018 to treat PNH.
Jodi Mayfield, MD, MS
Institution
University of New Mexico Comprehensive Cancer Center
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Pediatric
About
Dr. Jodi Mayfield is an Assistant Professor of Pediatric Hematology/Oncology and Stem Cell research at the University of New Mexico. She received her MD from the University of New Mexico Health Sciences Center in 2008. She is currently a member of the American Society of Hematology and the Children's Oncology Group. Dr. Mayfield's areas of practice include Stem Cell transplantation, Acute Leukemias, and Bone Marrow failure in Children. Publications Pinto N*, Mayfield JR*, Raca G, et al. Segmental Chromosomal Aberrations in Localized Neuroblastoma Can be Detected in Formalin-Fixed Paraffin
I'm Like You: Ricky Smith, Jr.
29-year-old Ricky Smith, Jr.
Anderson Family Pulls Together to Create Awareness for Aplastic Anemia
After Liviya’s diagnosis of severe aplastic anemia aplastic anemia: (ay-PLASS-tik uh-NEE_mee-uh) A rare and serious condition in which the bone marrow fails to make enough bloo
My Son's Aplastic Anemia
My son Jamie was a very sick child. He was in full-time daycare at the age of 12 months, so he caught every cold and infection imaginable.
Akiko Shimamura, MD
Institution
Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
Physician Status
accepting new patients
Primary Disease Area of Focus
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Pediatric
About
Dr. Akiko Shimamura directs the Bone Marrow Failure and Myelodysplastic Syndrome Program of the Dana Farber/Boston Children’s Cancer and Blood Disorders Center. Her research focuses on translational studies spanning clinical through basic science investigations to understand the genetic and molecular basis of bone marrow failure, MDS, and leukemia predisposition with the goal of developing more effective and less toxic treatments. Dr. Shimamura had previously directed the Bone Marrow Failure Clinic at Boston Children’s Hospital and then at Seattle Children’s Hospital before returning to Boston
Kasiani Myers, MD
Institution
Cincinnati Children’s Hospital Medical Center
Physician Status
accepting new patients
Primary Disease Area of Focus
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Pediatric
About
Dr. Kasiani Myers received her medical degree from Case Western Reserve University and pursued training in pediatrics and hematology/oncology at Cincinnati Children’s Hospital Medical Center. After completion of her postdoctoral training, she joined the faculty of the Division of Bone Marrow Transplantation and Immune Deficiency at Cincinnati Children’s Hospital Medical Center within the University of Cincinnati Department of Pediatrics. She is a recipient of the Procter Scholar Award to support her translational research in the field of bone marrow failure, including Fanconi anemia and
